Adhikari, UK; Khan, R; Mikhael, M; Balez, R; David, MA; Mahns, D; Hardy, J; Adhikari, UK; Khan, R; Mikhael, M; Balez, R; David, MA; Mahns, D; Hardy, J; Tayebi, M; - view fewer (2022) Therapeutic anti-amyloid β antibodies cause neuronal disturbances. Alzheimer's & Dementia 10.1002/alz.12833. (In press).

Preview	Text (Article) Hardy_Therapeutic Anti-Amyloid β Antibodies Cause Neuronal Disturbances.pdf Download (466kB) | Preview
Preview	Text (Research in context) Hardy_RESEARCH IN CONTEXT.pdf Download (58kB) | Preview
Preview	Text (Figures) Hardy_Figures.pdf Download (1MB) | Preview
Preview	Text (Tables) Hardy_Tables.pdf Download (117kB) | Preview
Preview	Text (Supplementary figures) Hardy_Supplementary Figures.pdf Download (2MB) | Preview
Preview	Text (Supplementary tables) Hardy_Supplementary Tables.pdf Download (3MB) | Preview

Abstract

Introduction: Recent published clinical trial safety data showed that 41% of Alzheimer patients experienced amyloid-related imaging abnormalities (ARIA), marks of microhemorrhages and edema in the brain, following administration of Biogen's Aduhelm/aducanumab (amino acids 3-7 of the Aβ peptide). Similarly, Janssen/Pfizer's Bapineuzumab (amino acids 1-5 of the Aβ peptide) and Roche's Gantenerumab (amino acids 2-11/18-27 of the Aβ peptide) also displayed ARIA in clinical trials, including microhemorrhage and focal areas of inflammation or vasogenic edema, respectively. The molecular mechanisms underlying ARIA caused by therapeutic anti-Aβ antibodies remain largely unknown, however, recent reports demonstrated that therapeutic anti-prion antibodies activate neuronal allergenic proteomes following cross-linking cellular prion protein. / Methods: Here, we report that treatment of human induced pluripotent stem cells- derived neurons (HSCN) from a non-demented donor, co-cultured with human primary microglia with anti-Aβ1-6, or anti-Aβ17-23 antibodies activate a significant number of allergenic-related proteins as assessed by mass spectrometry. / Results: Interestingly, a large proportion of the identified proteins included cytokines such as interleukin (IL)-4, IL-12, and IL-13 suggesting a type-1 hypersensitivity response. Following flow cytometry analysis, several proinflammatory cytokines were significantly elevated following anti-Aβ1-6, or anti-Aβ17-23 antibody treatment. / Discussion: These results justify further and more robust investigation of the molecular mechanisms of ARIA during immunotherapy study trials of AD. / HIGHLIGHTS: Allergenic-related proteins are often linked with Alzheimer's disease (AD). We investigated the effects of amyloid beta (Aβ) immunotherapy on stem cell derived neurons and primary neuronal cells co-cultured with microglia. Anti-Aβ antibody treatment of neurons or neurons co-cultured with microglia led to activation of a substantial number of allergenic-related genes. These allergenic-related genes are associated with endothelial dysfunction possibly responsible for ARIA.

Download activity - last month

Export as XMLCSVJSON

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item